- GlobeNewswire•7 days ago
Pernix Therapeutics to Report Fourth Quarter and Year-End 2016 Financial Results on Tuesday, March 28
MORRISTOWN, N.J., March 15, 2017-- Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company with a focus on Pain and CNS conditions, announced today that the Company will report financial ...
- Accesswire•28 days ago
Biotech's Rise Shows No Sign of Slowing Dow in 2017: Today's Reports on Pernix Therapeutics and Brainstorm Cell Therapeutics
NEW YORK, NY / ACCESSWIRE / February 23, 2017 / The Biotech Industry has posted some impressive gains since election result and the rally has continued for the larger part of this year. Both the iShares ...
- GlobeNewswire•28 days ago
MORRISTOWN, N.J., Feb. 23, 2017-- Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company with a focus on Pain and CNS conditions, announced today that it received a favorable opinion in ...
PTX : Summary for Pernix Therapeutics Holdings, I - Yahoo Finance
Pernix Therapeutics Holdings, Inc. (PTX)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Ask||4.02 x 300|
|Day's Range||3.77 - 3.97|
|52 Week Range||0.39 - 4.80|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-0.17|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|